June 1992
Volume 33, Issue 7
Free
Articles  |   June 1992
The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells.
Author Affiliations
  • H T Steely
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
  • S L Browder
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
  • M B Julian
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
  • S T Miggans
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
  • K L Wilson
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
  • A F Clark
    Department of Glaucoma Research, Alcon Laboratories, Fort Worth, Texas 76134.
Investigative Ophthalmology & Visual Science June 1992, Vol.33, 2242-2250. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H T Steely, S L Browder, M B Julian, S T Miggans, K L Wilson, A F Clark; The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells.. Invest. Ophthalmol. Vis. Sci. 1992;33(7):2242-2250.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Topical administration of glucocorticoids to the eye can lead to the development of ocular hypertension. This increase in intraocular pressure is caused by the heightened resistance to flow of aqueous humor from the eye, presumably at the trabecular meshwork (TM). This study reports the effects of dexamethasone (DEX) on the expression of the extracellular matrix protein fibronectin (FN) in cultured human TM cells (HTM). The expression of FN was evaluated in four HTM cell strains by epifluorescence microscopy and immunoblotting and autofluorography of electrophoretically separated cell proteins. There was a heterogeneous response of the four cell strains tested. Treatment of cell strain HTM4 with DEX (10(-7) mol/l) for 17 d caused an approximate doubling of cell-associated and secreted FN. This DEX-induced increase in FN expression was progressive after the first 7 d of treatment and was blocked partially with a glucocorticoid antagonist, cortexolone. By contrast, DEX treatment induced an intermediate 50-60% increase in FN expression in cell strains HTM10 and HTM2; in HTM6, FN was unchanged after exposure to the glucocorticoid. This model system may be useful to examine molecular changes associated with corticosteroid-induced ocular hypertension and evaluate glaucomatous changes in the TM because increased FN deposition occurs in the aqueous humor outflow pathway of patients with open-angle glaucoma.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×